Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): A randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
To see if Semaglutide is best for you, call us at 801-747-2273 and schedule a consultation with one of our providers to learn how we can help you live a better, healthier life
Schedule your appointment to build your customized plan with our specialists, or get started wherever you go with our online treatment planning tool!
& Di Franco, M
6a, the mice in the control group presented numerous A plaques stained by 6E10, whereas treatment with (-)-Vestitol, Salviolone, their combination, and Donepezil reduced the A plaque burden to varying extents